Wang Y, Wen Q, Lu Y, Yang J, et al. Identifying subgroups benefiting from intensive glycaemic treatment to improve renal outcomes in type 2 diabetes: Insights from the ACCORD trial. Diabetes Obes Metab 2024 Dec 9. doi: 10.1111/dom.16111.
PMID: 39654068